Extending Federal Funding for CHIP: What is at Stake?
This fact sheet provides an overview of the status of action to extend federal funding for the Children’s Health Insurance Program (CHIP).
View the Latest: Children
Filter
-
-
KFF COVID-19 Vaccine Monitor: February 2022
Poll FindingTwo years into the COVID-19 pandemic, the public is split on their readiness to return to normal, with many worried about the consequences of lifting restrictions and of not lifting them. At this point, the pandemic is not a top issue for voters in November's midterm elections . Most parents are not confident in the safety of the vaccine for kids under 5.
-
The Last Major Phase of the COVID-19 Vaccination Roll-out: Children Under 5
Issue BriefWith the FDA authorization of both Moderna and Pfizer’s COVID-19 vaccine for children between the ages of 6 months and 5, the last major phase of the U.S. vaccination roll-out is underway. This brief provides an overview of the characteristics of children under the age of 5 and discusses some issues to consider in rolling out vaccination to this age group.
-
KFF COVID-19 Vaccine Monitor: January 2022 Parents And Kids Update
Poll FindingThis Vaccine Monitor survey finds an increase in the share of parents reporting their child has received a COVID-19 vaccine, with 61% of parents of 12-17-year olds and 33% of 5-11-year-olds now saying their child has gotten at least one shot. Three in ten parents of children under the age of 5, a group that has not yet been approved to get a vaccine, say they’ll get their child vaccinated right away.
-
KFF’s Kaiser Health News Wins NABJ Award for Excellence in Radio Journalism for a Story About Teaching Children to Cope with the Constant Threat of Gun Violence in Their Communities
News ReleaseThe National Association of Black Journalists has recognized KFF’s Kaiser Health News and two of its editorial partners with a 2021 “Salute to Excellence” award for a radio story about how children are taught to cope and survive in communities beset by gun violence.
-
Measles Vaccines and Misinformation in the Courts: A Snapshot From the KFF Health Misinformation Tracking Poll
FeatureThe latest KFF Health Misinformation Tracking Poll examines misinformation related to the measles vaccine and the public’s views of the U.S. government and social media companies’ role in moderating false claims online.
-
The Impact of the Pandemic on Well-Child Visits for Children Enrolled in Medicaid and CHIP
Issue BriefThis issue brief examines well-child visit rates overall and for selected characteristics before and after the pandemic began and discusses recent state and federal policy changes that could impact children’s preventive care. More than half of children under age 21 enrolled in Medicaid or CHIP received a well-child visit in 2019, but the share fell to 48% in 2020, the start of the COVID-19 pandemic.
-
Obesity Rates Among Children: A Closer Look at Implications for Children Covered by Medicaid
Issue BriefThis brief examines the share of children with obesity, how obesity screening and treatment is covered under Medicaid for children, and what recent changes may mean for Medicaid programs and enrollees in the future.
-
Headed Back To School in 2023: A Look at Children’s Routine Vaccination Trends
Issue BriefThis issue brief examines the most recent trends in children’s routine vaccinations, including COVID-19, and explores what to watch as children head back to school this year.
-
Teens, Drugs, and Overdose: Contrasting Pre-Pandemic and Current Trends
Issue BriefThis brief analyzes the latest CDC data on adolescent overdose deaths, finding that from 2022 to 2023, there was a small reduction in overdose fatalities among adolescents (from 721 to 708 deaths). Additionally, the synthetic opioid, fentanyl, has largely driven the increase in adolescent drug fatalities since the pandemic began, accounting for 76% of these fatalities in 2023. This analysis also explores federal and state policy responses to the drug crisis, such as requirements to stock naloxone in schools, accountability for social media companies, and national prevention education efforts.